Your browser doesn't support javascript.
loading
PINK1-mediated mitophagy contributes to glucocorticoid-induced cathepsin K production in osteocytes.
Yuan, Jun; Gao, You-Shui; Liu, De-Lin; Pang Tai, Andrew Chi; Zhou, Hong; Papadimitriou, John M; Zhang, Chang-Qing; Zheng, Ming-Hao; Gao, Jun-Jie.
Afiliação
  • Yuan J; Centre for Orthopaedic Translational Research, Medical School, The University of Western Australia, Nedlands, Western Australia, 6009, Australia.
  • Gao YS; Perron Institute for Neurological and Translational Science, Nedlands, Western Australia, 6009, Australia.
  • Liu DL; Department of Orthopaedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, 200233, China.
  • Pang Tai AC; Centre for Orthopaedic Translational Research, Medical School, The University of Western Australia, Nedlands, Western Australia, 6009, Australia.
  • Zhou H; Perron Institute for Neurological and Translational Science, Nedlands, Western Australia, 6009, Australia.
  • Papadimitriou JM; Centre for Orthopaedic Translational Research, Medical School, The University of Western Australia, Nedlands, Western Australia, 6009, Australia.
  • Zhang CQ; Perron Institute for Neurological and Translational Science, Nedlands, Western Australia, 6009, Australia.
  • Zheng MH; Bone Research Program, ANZAC Research Institute, The University of Sydney, Sydney, NSW, Australia.
  • Gao JJ; Pathwest Laboratories and Faculty of Health and Medical Sciences, The University of Western Australia, Nedlands, WA, 6009, Australia.
J Orthop Translat ; 38: 229-240, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36474855
ABSTRACT

Background:

Glucocorticoid (GC) is one of frequently used anti-inflammatory agents, but its administration is unfortunately accompanied with bone loss. Although sporadic studies indicated that osteocytes are subject to a series of pathological changes under GC stress, including overexpression of cathepsin K, the definite role of osteocytes in GC-induced bone loss remains largely unclear.

Methods:

Gene expression of Ctsk and protein levels of cathepsin K were assessed in MLO-Y4 cell lines exposed to dexamethasone (Dex) of different time (0, 12, 24 hours) and dose (0, 10-8 and 10-6 M) courses by RT-qPCR and western blotting, respectively. Confocal imaging and immunostaining were then performed to evaluate the effects of osteocyte-derived cathepsin K on type I collagen in a primary osteocyte ex vivo culture system. MitoTracker Red was used to stain mitochondria for mitochondria morphology assessment and JC-1 assay was employed to evaluate the mitochondria membrane potential in MLO-Y4 cells following Dex treatment. Activation of PINK1-mediated mitophagy was evaluated by immunostaining of the PINK1 protein and CytoID assay. Mdivi-1 was used to inhibit mitophagy and siRNAs were used for the inhibition of Pink1 and Atg5.

Results:

GC triggered osteocytes to produce excessive cathepsin K which in turn led to the degradation of type I collagen in the extracellular matrix in a primary osteocyte ex vivo culture system. Meanwhile, GC administration increased mitochondrial fission and membrane depolarization in osteocytes. Further, the activation of PINK1-mediated mitophagy was demonstrated to be responsible for the diminishment of dysfunctional mitochondria in osteocytes. Examination of relationship between mitophagy and cathepsin K production revealed that inhibition of mitophagy via knocking down Pink1 gene abolished the GC-triggered cathepsin K production. Interestingly, GC's activation effect towards cathepsin K via mitophagy was found to be independent on the canonical autophagy as this effect was not impeded when inhibiting the canonical autophagy via Atg5 suppression.

Conclusion:

GC-induced PINK1-mediated mitophagy substantially modulates the production of cathepsin K in osteocytes, which could be an underlying mechanism by which osteocytes contribute to the extracellular matrix degradation during bone loss. The Translational potential of this article Findings of the current study indicate a possible role of osteocyte mitophagy in GC-induced bone loss, which provides a potential therapeutic approach to alleviate GC-induced osteoporosis by targeting PINK1-mediated osteocytic mitophagy.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Orthop Translat Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Orthop Translat Ano de publicação: 2023 Tipo de documento: Article